|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 808.48 USD | +3.08% |
|
+5.24% | +3.51% |
| Market Cap | 78.32B 67.8B 63.38B 57.92B 109B 7,470B 111B 743B 292B 3,737B 294B 288B 12,446B | P/E 2026 * |
18.5x | P/E 2027 * | 15.6x |
|---|---|---|---|---|---|
| Enterprise Value | 71.45B 61.86B 57.82B 52.84B 99.58B 6,815B 101B 678B 266B 3,409B 268B 262B 11,355B | EV / Sales 2026 * |
4.23x | EV / Sales 2027 * | 3.7x |
| Free-Float |
71.07% | Yield 2026 * |
0.5% | Yield 2027 * | 0.57% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +2.40% | ||
| 1 week | +5.24% | ||
| Current month | +4.77% | ||
| 1 month | +20.24% | ||
| 3 months | +12.10% | ||
| 6 months | +5.84% | ||
| Current year | +3.51% |
| 1 week | 747 |  | 809.09 |
| 1 month | 637.8 | | 809.09 |
| Current year | 591.52 | | 821.11 |
| 1 year | 541 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/7/26 | Sell | Director | -200 | 0.0002% | ||
| 19/2/26 | Fiscal year | Director | 4,914 | 0.0048% | ||
| 9/2/26 | Fiscal year | SVP Controller | 4,036 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.08% | +5.24% | +46.35% | +0.75% | 78.32B | |
| +0.84% | +5.66% | -0.15% | +27.88% | 51.1B | |
| +0.90% | +0.99% | +22.01% | +176.13% | 49.18B | |
| +1.72% | +9.27% | -48.46% | -48.80% | 44.71B | |
| -0.33% | +2.61% | +61.78% | -23.04% | 30.72B | |
| +0.86% | +2.91% | +53.91% | +86.05% | 24.44B | |
| +0.39% | +7.93% | +133.65% | -40.66% | 23.62B | |
| +2.58% | +12.23% | +6.63% | +202.17% | 21.05B | |
| -0.62% | -4.29% | +65.10% | +117.79% | 16.61B | |
| +0.26% | +6.09% | +75.85% | +161.90% | 16.51B | |
| Average | +1.03% | +5.48% | +41.67% | +66.02% | 35.63B | |
| Weighted average by Cap. | +1.27% | +5.21% | +31.95% | +48.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.89B 14.62B 13.67B 12.49B 23.54B 1,611B 23.9B 160B 62.88B 806B 63.42B 62.03B 2,684B | 18.34B 15.88B 14.84B 13.56B 25.56B 1,749B 25.96B 174B 68.29B 875B 68.87B 67.36B 2,914B |
| Net income | 4.61B 3.99B 3.73B 3.41B 6.42B 439B 6.52B 43.71B 17.15B 220B 17.3B 16.92B 732B | 5.35B 4.63B 4.33B 3.96B 7.46B 510B 7.58B 50.79B 19.93B 255B 20.1B 19.66B 851B |
| Net Debt | -6.87B -5.95B -5.56B -5.08B -9.57B -655B -9.72B -65.17B -25.57B -328B -25.79B -25.23B -1,091B | -10.55B -9.14B -8.54B -7.8B -14.71B -1,007B -14.94B -100B -39.3B -504B -39.63B -38.76B -1,677B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/08/26 | USD 808.54 | +3.08% | 596,880 |
| 07/08/26 | USD 784.36 | +1.59% | 837,598 |
| 06/08/26 | USD 772.11 | +0.46% | 783,950 |
| 05/08/26 | USD 768.58 | +1.04% | 532,482 |
| 04/08/26 | USD 760.66 | +0.19% | 817,280 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
